UBE2E3 and breast carcinoma: miR-124-3p appears to be a tumor suppressorin breast cancer cells and it acts via targeting CBL (Cblproto-oncogene, E3 ubiquitin protein ligase) (13).However, the molecular pathways underlying miR-124modulatory actions in breast cancer cells are notfully understood.